PPXRD - Pharmaceutical X-ray Diffraction Symposium

PPXRD-10 Presentations

[sc_textbox content_background_style=”cover” content_background_position_vertical=”center” content_background_image=”34977″]

 PPXRD-10 Presentations


May 2011 – Lyon, France

[sc_table row_headers=”1″]


Presentation Title Authors
‣ Using XRD to monitor the influence of milling on physical properties of a hydrate Itai Adin, Chemagis Ltd., Israel
In situ Measurement and Characterization of Crystal Growth by X-ray Diffraction – Crystallization Monitoring – a QbD tool – Detlef Beckers, PANalytical B.V., The Netherlands
‣ Stability and Desolvation Kinetics of Droperidol Hydrates and an Ethonal Solvate, Studied by Powder X-ray Diffraction and Differental Thermal Analysis/Termogravimetry Agris Berzins, University of Latvia, Riga, Latvia
Total Scattering Pair Distribution Functions (TSPDF) for Fingerprinting Amorphous Pharmaceuticals Simon Billinge, Columbia University, New York, NY, USA
A Novel Method to Determine Amorphous Phase Concentrations Using the Rietveld Refinement Technique Xim Bokhimi, Institute of Physics, Universidad NacionalAutónomade México (UNAM)
Addressing the challenges in applying crystal structure prediction to pharmaceutical materials Graeme M. Day, Department of Chemistry, University of
Cambridge, Cambridge, UK
Reference Materials for the Study of Polymorphism and Crystallinity of Cellulose Tim Fawcett, ICDD, Newtown Square, PA, USA
Application of Automated Electron Diffraction to Structural Investigation of Molecular Crystals Tatiana Gorelik, Johannes-Gutenberg University Mainz, Mainz, Germany
VÅNTEC-500 Area Detector for Pharmaceutical XRD Bob He, Bruker AXS Inc, Madison, WI, USA
Investigation of Solid-state Stability of a Co-crystal API in Formulation Development by XRPD and ss- NMR Spectroscopy Z. Jane Li, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA
An Overview of Solid Form Screening During Drug Development Ann Newman, SeventhStreet Development Group, Lafayette, IN, USA
NEW techniques for TEM – nanoanalysis  precession electron diffraction for organic  –  inorganic nanostructures Stavros Nikolopoulos, NanoMEGAS SPRL, Brussels, Belgium
HR-XRPD and Polymorph Stability Ivo B. Rietveld, Universite Paris Descartes, Paris, France
‣ Complementary Crystallography and X-ray Powder Diffraction Methods Greg Stephenson, Lilly Research Laboratories, Eli Lilly and
Company,Indianapolis, IN, USA
Effect of Processing Conditions on the Physical State of Solutes in Lyophilized Formulations Prakash Sundaramurthi, Scientific Affairs, Teva Parenteral
Medicines. Inc., Irvine CA, USA
Polymorphism and Solvates of Flecainide Base Kaspar Veldre, University of Latvia, Riga, Latvia




PPXRD-10 Photos
Scroll to Top